Formulation & Drug Delivery Division

Download

Overview

The research activities in the Formulation & Drug Delivery Division comprise formulation development for the institutional leads. The novel delivery systems based formulation strategies are also explored in order to improve bioavailability and therapeutic efficacy of the chemotherapeutic agent(s). The division also supports formulation related preclinical studies for the drug development programme of the institute.

Mission and goals

	Preclinical formulation development to support drug development programme of the institute.
	Novel drug delivery systems based innovative formulation development
	Conducts and supports research, training, and other programs with respect to formulation development.

Competencies

	Preclinical formulation development
	Novel delivery system based formulation development
	In-vitro characterization of formulation
	Preformulation studies

People:

Sr. NO	Name	Expertise	E-mail
1.	Dr. P. N. Gupta	Formulation & drug delivery	pngupta[at]iiim[dot]res[dot]in

Area of research

Formulation & drug delivery

Facilities

	Facilities for formulation development at laboratory scale
	Ultrasonic homogenizer
	Centrifuge
	Particle size analysis
	Optical microscope
	Vortexer

Current research

	Formulation development for the institutional leads
	Formulation development for the bioavailability enhancement
	Polymeric delivery systems for improved efficacy of anticancer agent(s).
	Pre-formulation studies.

Projects

Project Title

Preclinical developments of botanical leads and NCEs for IND phase (MLP6008)

Preclinical studies of new bioactive leads and development of new combination drugs for cancer/tuberculosis (MLP6006)

Development & evaluation of novel strategies based on polymeric carrier and drug combination for cancer chemotherapy (DST sponsored project).

Nurturing a new Pan-CSIR drug pipe line: high intensity preclinical, clinical studies on lead candidates (BSC-0205).